Abstract
At present, chemotherapy seems to be the main weapon in the arsenal of remedies for the ongoing crusade against AIDS. The mode of binding of the TIBO family of inhibitors has been of interest because these compounds do not fit the two-hinged-ring model as generally observed in the NNRTIs. Flexible docking simulations were performed with a series of 53 TIBO derivatives as NNRTIs. Binding preferences as well as the structural and energetic factors associated with them were studied. A good correlation (r 2 = 0.849, q 2 = 0.843) was observed between the biological activity and binding affinity of the compounds which suggest that the identified binding conformations of these inhibitors are reliable. Further screening of PubChem database yielded novel scaffolds. Our studies suggest that modifications to the TIBO group of inhibitors might enhance their binding efficacy and hence, potentially, their therapeutic utility.
Similar content being viewed by others
References
Silvestri R, Maga G (2006) Expert Opin Ther Pat 16:939
Matthis G, Torsten U, Danielson U (2006) J Med Chem 49:2375
Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Ashman DJ, Holmberg SD (1998) N Engl J Med 338:853
Palella FJ, Chmiel JS, Moorman AC, Holmberg SD (2002) AIDS 16:1617
De Clercq E (1998) Antiviral Res 38:153
De Clercq E (2004) Chem Biodivers 1:44
De Clercq E (2005) J Med Chem 10:1297
Kohlstaedt LA, Wang J, Friedman JM, Rice PA, Steitz TA (1992) Science 256:1783
Ren J, Esnouf R, Garman E, Somers D, Ross C, Kirby I, Keeling J, Darby G, Jones Y, Stuart D, Stammers D (1995) Nat Struct Biol 2:293
Ding J, Das K, Tantillo C, Zhang W, Clark ADJ, Pauwels R, Moereels H, Koymans L, Janssen PAJ, Smith RHJ, Kroeger Koepke R, Michejda CJ, Hughes SH, Arnold E (1995) Structure 3:365
Deeks SG (2001) J AIDS 26:S25
Tavel JA, Miller KD, Masur H (1999) Clin Infect Dis 28:643
Das K, Levi PJ, Hughes SH, Arnold E (2005) Prog Biophys Mol Biol 88:209
Zhou Z, Lin X, Madura JD (2006) Infect Disord Drug Targets 6:391
De Clercq E (2001) Curr Med Chem 8:1543
Campiani G, Ramunno A, Maga G, Nacci V, Fattorusso C, Catalanotti B, Morelli E, Novellino E (2002) Curr Pharm Des 8:615
Hannongbua S, Lawtrakul L, Limtrakul J (1996) J Comput Aided Mol Des 10:145
Hannongbua S, Pungpo P, Limtrakul J, Wolschann P (1999) J Comput Aided Mol Des 13:563
Garg R, Gupta SP, Gao H, Babu MS, Debnath AK, Hansch C (1991) Chem Rev 99:3525
Zhou Z, Madura JD (2004) J Chem Inf Comput Sci 44:2167
Barreca ML, Rao A, De Luca L, Zappala M, Monforte AM, Maga G, Pannecouque C, Balzarini J, De Clercq E, Chimirri A, Monforte P (2005) J Med Chem 48:3433
D’Cruz OJ, Uckun FM (2006) J Antimicrob Chemother 57:411
Pauwels R, Andries K, Desmyter J, Schols D, Kukla MJ, Breslin HJ, Raeymaeckers A, Van Gelder J, Woestenborghs R, Heykants J (1990) Nature 343:470
Ren J, Esnouf R, Hopkins A, Ross C, Jones Y, Stammers D, Stuart D (1995) Structure 3:915
Zhou Z, Madura JD (2004) J Chem Inf Comput Sci 44:2167
De Clercq E (1995) Clin Microbiol Rev 8:200
Das K, Ding J, Hsiou Y, Clark AJ, Moereels H, Koymans L, Andries K, Pauwels R, Janssen P, Boyer P, Clark P, Smith RJ, Kroeger SM, Michejda C, Hughes S, Arnold E (1996) J Mol Biol 264:1085
Ding J, Das K, Moereels H, Koymans L, Andries K, Janssen PA, Hughes SH, Arnold E (1995) Nat Struct Biol 2:407
Bahram H, Mohammad Hossein Tabaei S, Fatemeh N (2005) J Mol Struct Theochem 732:39
Saen-oon S, Kuno M, Hannongbua S (2005) Proteins 61:859
Zhou Z, Madura JD (2004) Proteins 57:493
Rawal RK, Kumar A, Siddiqi IS, Katti SB (2007) J Mol Model 13:155
Rizzo RC, Wang DP, Tirado-Rives J, Jorgensen WL (2000) J Am Chem Soc 122:12898
Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE (2000) Nucleic Acids Res 28:235
Thomsen R, Christensen MH (2006) J Med Chem 49:3315
Storn R, Price K (1995) Differential evolution – a simple and efficient adaptive scheme for global optimization over continuous spaces. Technical Report, International Computer Science Institute, Berkley, CA
Thomsen R (2003) Flexible ligand docking using differential evolution. In: Proceedings of the 2003 congress on evolutionary computation, vol 4, pp 2354–2361
Gehlhaar DK, Verkhivker G, Rejto PA, Fogel DB, Fogel LJ, Freer ST (1995) Docking conformationally flexible small molecules into a protein binding site through evolutionary programming. In: Proceedings of the fourth international conference on evolutionary programming, pp 615–627
Gehlhaar DK, Bouzida D, Rejto PA (1998) Fully automated and rapid flexible docking of inhibitors covalently bound to serine proteases. In: Proceedings of the seventh international conference on evolutionary programming, pp 449–461
Yang JM, Chen CC (2004) Proteins 55:288
http://www.molegro.com (free trial version)
Mager PP (1997) Med Res Rev 17:235
Tantillo C, Ding J, Jacobo-Molina A, Nanni RG, Boyer PL, Hughes SH, Pauwels R, Andries K, Janssen PA, Arnold E (1994) J Mol Biol 243:369
Acknowledgement
The author wishes to acknowledge Dr. R. C. Saraswat, Director, S.G.S. I.T.S, Indore.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sapre, N.S., Gupta, S., Pancholi, N. et al. Molecular docking studies on tetrahydroimidazo-[4,5,1-jk][1,4]-benzodiazepinone (TIBO) derivatives as HIV-1 NNRT inhibitors. J Comput Aided Mol Des 22, 69–80 (2008). https://doi.org/10.1007/s10822-007-9161-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10822-007-9161-8